TickerFactsScreenerDevelopers

Decoy Therapeutics Inc. (DCOY) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$20.75M2016: -$32.05M2017: -$27.72M2018: $4.18M2019: -$11.58M2020: -$10.31M2021: -$10.20M2022: -$17.60M2023: -$12.85M2024: -$4.53M2025: -$4.83M-$4.83M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$4.83M-6.7%
2024-$4.53M+64.8%
2023-$12.85M+27.0%
2022-$17.60M-72.5%
2021-$10.20M+1.1%
2020-$10.31M+11.0%
2019-$11.58M-377.2%
2018$4.18M+115.1%
2017-$27.72M+13.5%
2016-$32.05M-54.5%
2015-$20.75M—